C
IART icon

Cerebellum’s Integra LifeSciences IART Stock Holding History

Cerebellum’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,946
Closed -$297K – 476
2019
Q3 		$297K Buy
+4,946
New +$295K 0.19% 343
2019
Q1 		– Sell
-5,422
Closed -$245K – 487
2018
Q4 		$245K Buy
+5,422
New +$297K 0.17% 224

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Cerebellum's IART Position: Q4 2019 in Review

Cerebellum sold out of Integra LifeSciences (IART) in Q4 2019, closing a stake of 4,946 shares — an estimated $297K sold.

Cerebellum first reported a position in IART in Q4 2018 and held it in 2 quarters. The position peaked at $297K in Q3 2019. 279 funds tracked by Wall St. Rank hold IART as of Q4 2019.

  • Cerebellum reported no remaining Integra LifeSciences position as of Q4 2019 after selling out during the quarter.
  • Cerebellum sold 4,946 Integra LifeSciences shares in Q4 2019, an estimated $297K.
  • Cerebellum first reported a position in Integra LifeSciences in Q4 2018 and held it in 2 quarters.
  • Cerebellum's Integra LifeSciences position peaked at $297K in Q3 2019.
  • 279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2019.

Based on Cerebellum's 13F filing for Q4 2019, filed 16 Jan 2020.